» Articles » PMID: 22628435

Angiopoietin-1 and Vascular Endothelial Growth Factor Regulation of Leukocyte Adhesion to Endothelial Cells: Role of Nuclear Receptor-77

Overview
Date 2012 May 26
PMID 22628435
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Vascular endothelial growth factor (VEGF) promotes leukocyte adhesion to endothelial cells (ECs). Angiopoietin-1 (Ang-1) inhibits this response. Nuclear receptor-77 (Nur77) is a proangiogenic nuclear receptor. In the present study, we assessed the influence of Ang-1 and VEGF on Nur77 expression in ECs, and evaluated its role in Ang-1/VEGF-mediated leukocyte adhesion.

Methods And Results: Expression of Nur77 was evaluated with real-time polymerase chain reaction and immunoblotting. Adhesion of leukocytes to ECs was monitored with inverted microscopy. Nur77 expression or activity was inhibited using adenoviruses expressing dominant-negative form of Nur77, retroviruses expressing Nur77 in the antisense direction, and small interfering RNA oligos. Both Ang-1 and VEGF induce Nur77 expression, by >5- and 30-fold, respectively. When combined, Ang-1 potentiates VEGF-induced Nur77 expression. Ang-1 induces Nur77 through the phosphoinositide 3-kinase and extracellular signal-regulated protein kinase 1/2 pathways. VEGF induces Nur77 expression through the protein kinase D/histone deacetylase 7/myocyte enhancer factor 2 and extracellular signal-regulated protein kinase 1/2 pathways. VEGF induces nuclear factor-kappaB transcription factor, vascular cell adhesion molecule-1, and E-selectin expressions, and promotes leukocyte adhesion to ECs. Ang-1 inhibits these responses. This inhibitory effect of Ang-1 disappears when Nur77 expression is disrupted, restoring the inductive effects of VEGF on adhesion molecule expression, and increased leukocyte adhesion to ECs.

Conclusions: Nur77 promotes anti-inflammatory effects of Ang-1, and functions as a negative feedback inhibitor of VEGF-induced EC activation.

Citing Articles

Targeting intracellular proteins with cell type-specific functions for cancer immunotherapy.

Carelock M, Master R, Kim M, Jin Z, Wang L, Maharjan C Life Med. 2025; 2(3):lnad019.

PMID: 39872303 PMC: 11749652. DOI: 10.1093/lifemedi/lnad019.


PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy.

Wang L, Xiao Y, Luo Y, Master R, Mo J, Kim M J Exp Med. 2024; 221(3).

PMID: 38334978 PMC: 10857906. DOI: 10.1084/jem.20231519.


HDAC1 disrupts the tricarboxylic acid (TCA) cycle through the deacetylation of Nur77 and promotes inflammation in ischemia-reperfusion mice.

Wu Z, Bai Y, Qi Y, Chang C, Jiao Y, Bai Y Cell Death Discov. 2023; 9(1):10.

PMID: 36653355 PMC: 9849262. DOI: 10.1038/s41420-023-01308-1.


Differential mRNA Expression Profiling Reveals the Role of MiR-375 in Inflammation of Bovine Mammary Epithelial Cells.

Li Y, Hu Q, Luoreng Z, Yang J, Wang X, Ma Y Animals (Basel). 2022; 12(11).

PMID: 35681895 PMC: 9179474. DOI: 10.3390/ani12111431.


Angiogenesis, Lymphangiogenesis, and Inflammation in Chronic Obstructive Pulmonary Disease (COPD): Few Certainties and Many Outstanding Questions.

Poto R, Loffredo S, Palestra F, Marone G, Patella V, Varricchi G Cells. 2022; 11(10).

PMID: 35626756 PMC: 9139415. DOI: 10.3390/cells11101720.


References
1.
Kolluri S, Bruey-Sedano N, Cao X, Lin B, Lin F, Han Y . Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells. Mol Cell Biol. 2003; 23(23):8651-67. PMC: 262666. DOI: 10.1128/MCB.23.23.8651-8667.2003. View

2.
Kim I, Moon S, Kim S, Kim H, Koh Y, Koh G . Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem. 2000; 276(10):7614-20. DOI: 10.1074/jbc.M009705200. View

3.
Altschmied J, Haendeler J . A new kid on the block: PKD1: a promising target for antiangiogenic therapy?. Arterioscler Thromb Vasc Biol. 2008; 28(10):1689-90. DOI: 10.1161/ATVBAHA.108.174250. View

4.
Melder R, Koenig G, Witwer B, Safabakhsh N, Munn L, Jain R . During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med. 1996; 2(9):992-7. DOI: 10.1038/nm0996-992. View

5.
Darragh J, Soloaga A, Beardmore V, Wingate A, Wiggin G, Peggie M . MSKs are required for the transcription of the nuclear orphan receptors Nur77, Nurr1 and Nor1 downstream of MAPK signalling. Biochem J. 2005; 390(Pt 3):749-59. PMC: 1199668. DOI: 10.1042/BJ20050196. View